Cardiac and Kidney Benefits of Empagliflozin in Heart Failure Across the Spectrum of Kidney Function

Cardiac and Kidney Benefits of Empagliflozin in Heart Failure Across the Spectrum of Kidney Function is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Cardiac and Kidney Benefits of Empagliflozin in Heart Failure Across the Spectrum of Kidney Function have?

Cardiac and Kidney Benefits of Empagliflozin in Heart Failure Across the Spectrum of Kidney Function has 281 citations in the OpenAlex counts ScholarIQ stores.

When was Cardiac and Kidney Benefits of Empagliflozin in Heart Failure Across the Spectrum of Kidney Function published?

Cardiac and Kidney Benefits of Empagliflozin in Heart Failure Across the Spectrum of Kidney Function has 2020 year in the ScholarIQ index.

What is the open-access status of Cardiac and Kidney Benefits of Empagliflozin in Heart Failure Across the Spectrum of Kidney Function?

Cardiac and Kidney Benefits of Empagliflozin in Heart Failure Across the Spectrum of Kidney Function has hybrid oa status in the ScholarIQ index.

What is the DOI of Cardiac and Kidney Benefits of Empagliflozin in Heart Failure Across the Spectrum of Kidney Function?

The DOI for Cardiac and Kidney Benefits of Empagliflozin in Heart Failure Across the Spectrum of Kidney Function is on the source record.

What is the PMID of Cardiac and Kidney Benefits of Empagliflozin in Heart Failure Across the Spectrum of Kidney Function?

The PMID for Cardiac and Kidney Benefits of Empagliflozin in Heart Failure Across the Spectrum of Kidney Function is on the source record.

What is the OpenAlex record for Cardiac and Kidney Benefits of Empagliflozin in Heart Failure Across the Spectrum of Kidney Function?

The OpenAlex for Cardiac and Kidney Benefits of Empagliflozin in Heart Failure Across the Spectrum of Kidney Function is on the source record.